
|
Channels
|
|||||
|
Medical Health Encyclopedia
Anemia - Highlights
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
HighlightsErythropoiesis-Stimulating Drugs In 2006, the Food and Drug Administration (FDA) issued an advisory regarding treatment targets for erythropoiesis-stimulating drugs. These drugs include epoetin alfa (Procrit, Epogen, and Eprex) and darbepoetin alfa (Aranesp). They are used to treat severe anemia caused by other diseases, such as chronic kidney disease. Two 2006 studies in the New England Journal of Medicine indicated that aggressive dosing to completely normalize anemia (hemoglobin levels of 13.5 g/dL) provided no greater benefit than lower dosing to partially correct anemia (hemoglobin levels of 10 – 12 g/dL). Higher dosing and higher hemoglobin levels increased the risk for heart failure, heart attack, and stroke. ![]() In response to these studies, the FDA recommends that patients who take these drugs should:·
Anemia in the Elderly Mild anemia may cause difficulties with problem-solving abilities and other cognitive functions, suggests a 2006 study in the Journal of the American Geriatrics Society. Diagnosing Fetal Anemia Doppler ultrasonography may be better and safer than amniocentesis for diagnosing fetal anemia, according to a 2006 study in the New England Journal of Medicine. Doppler ultrasonography is a non-invasive imaging test. Investigational Drugs Eculizumab, an investigational monoclonal antibody drug, may help improve anemia in patients with paroxysmal nocturnal hemoglobinuria (PNH), indicates a 2006 study in the New England Journal of Medicine. PNH is a rare and severe form of hemolytic anemia. There are few treatment options for this condition.
Review Date: 01/17/2007 ![]() | |||||
|
Search
Special Offers
TV Specials
Top Features
Resources
Find a Therapist
PR Newswire
|
New Features
|
||||
|
|||||